Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sage Therapeutics
SAGE
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.50
-0.4
-5.06%
At Close: -
$7.66
0.16
2.13%
After Hours: Sep 20, 6:53 PM EDT
15 minutes delayed
Get Report
Comment
Sage Therapeutics (SAGE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sage Therapeutics (NASDAQ:SAGE) Stock
Sage Therapeutics Stock (NASDAQ: SAGE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, September 17, 2024
Sage Therapeutics Filed For Mixed Shelf; Size...
Benzinga Newsdesk
Wednesday, August 14, 2024
Truist Securities Maintains Hold on Sage Ther...
Benzinga Newsdesk
Tuesday, August 06, 2024
JP Morgan Maintains Neutral on Sage Therapeut...
Benzinga Newsdesk
Friday, August 02, 2024
HC Wainwright & Co. Reiterates Neutral on Sag...
Benzinga Newsdesk
Thursday, August 01, 2024
Sage Therapeutics shares are trading lower af...
Benzinga Newsdesk
Biogen Q2 Earnings & Sales Beat, 2024 Guidance Raised
Zacks
Piper Sandler Maintains Overweight on Sage Th...
Benzinga Newsdesk
Needham Reiterates Hold on Sage Therapeutics
Benzinga Newsdesk
Wednesday, July 31, 2024
Sage Anticipates That Its Existing Cash, Cash...
Benzinga Newsdesk
Sage Therapeutics Q2 EPS $(1.70) Misses $(1.6...
Benzinga Newsdesk
Tuesday, July 30, 2024
Expert Outlook: Sage Therapeutics Through The Eyes Of 14 Analysts
Benzinga Insights
TD Cowen Downgrades Sage Therapeutics to Hold...
Benzinga Newsdesk
Friday, July 26, 2024
Goldman Sachs Maintains Neutral on Sage Thera...
Benzinga Newsdesk
Thursday, July 25, 2024
Scotiabank Maintains Sector Outperform on Sag...
Benzinga Newsdesk
JP Morgan Downgrades Sage Therapeutics to Neu...
Benzinga Newsdesk
Baird Maintains Neutral on Sage Therapeutics,...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Sag...
Benzinga Newsdesk
Wednesday, July 24, 2024
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Sage, Biogen Shelve Development Of Nervous System Disorder Drug After Data Disappoints
Vandana Singh
Needham Reiterates Hold on Sage Therapeutics
Benzinga Newsdesk
Sage Therapeutics shares are trading lower af...
Benzinga Newsdesk
Sage, Biogen Report Results From Phase 2 KINE...
Benzinga Newsdesk
Friday, July 19, 2024
Netflix To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Mizuho Maintains Neutral on Sage Therapeutics...
Benzinga Newsdesk
Friday, July 12, 2024
Analyst Expectations For Sage Therapeutics's Future
Benzinga Insights
JP Morgan Maintains Overweight on Sage Therap...
Benzinga Newsdesk
Thursday, July 11, 2024
Delta Air Lines Posts Downbeat Earnings, Joins United Airlines, American Airlines And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Tuesday, July 02, 2024
HC Wainwright & Co. Reiterates Neutral on Sag...
Benzinga Newsdesk
Friday, June 28, 2024
Needham Reiterates Hold on Sage Therapeutics
Benzinga Newsdesk
Thursday, June 20, 2024
19 Analysts Have This To Say About Sage Therapeutics
Benzinga Insights
JP Morgan Maintains Overweight on Sage Therap...
Benzinga Newsdesk
Wednesday, June 12, 2024
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
HC Wainwright & Co. Reiterates Neutral on Sag...
Benzinga Newsdesk
Tuesday, June 11, 2024
Sage Therapeutics Reports Phase 2 Huntington's Data
Dylan Berman
Needham Reiterates Hold on Sage Therapeutics
Benzinga Newsdesk
Baird Maintains Neutral on Sage Therapeutics,...
Benzinga Newsdesk
Sage Therapeutics Says Phase 2 SURVEYOR Study...
Benzinga Newsdesk
Wednesday, May 29, 2024
Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
Benzinga Insights
Citigroup Initiates Coverage On Sage Therapeu...
Benzinga Newsdesk
Baird Initiates Coverage On Sage Therapeutics...
Benzinga Newsdesk
Tuesday, May 21, 2024
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Avi Kapoor
Tuesday, May 14, 2024
Sage Therapeutics CE Says Co Open To Partners...
Benzinga Newsdesk
Wednesday, May 01, 2024
JP Morgan Maintains Overweight on Sage Therap...
Benzinga Newsdesk
Friday, April 26, 2024
HC Wainwright & Co. Maintains Neutral on Sage...
Benzinga Newsdesk
Goldman Sachs Maintains Neutral on Sage Thera...
Benzinga Newsdesk
RBC Capital Maintains Sector Perform on Sage ...
Benzinga Newsdesk
Truist Securities Maintains Hold on Sage Ther...
Benzinga Newsdesk
Mizuho Maintains Neutral on Sage Therapeutics...
Benzinga Newsdesk
Canaccord Genuity Maintains Hold on Sage Ther...
Benzinga Newsdesk
Needham Reiterates Hold on Sage Therapeutics
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch